These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 9157576

  • 21. Estimating the cost of redundancy in molecular diagnostics: the case of activated protein C resistance and factor V Leiden.
    Rolla R, Vidali M, Meola S, Pollarolo P, Pergolini P, Bellomo G.
    Clin Lab; 2011; 57(9-10):711-7. PubMed ID: 22029186
    [Abstract] [Full Text] [Related]

  • 22. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
    Thomassen MC, Castoldi E, Tans G, Magdeleyns EJ, Delaunoit C, Debusscher L, Van Assche KJ, Rosing J.
    Haematologica; 2003 Oct; 88(10):1150-6. PubMed ID: 14555311
    [Abstract] [Full Text] [Related]

  • 23. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
    Bossone A, Cappucci F, D'Andrea G, Brancaccio V, Cibelli G, Iannaccone L, Grandone E, Margaglione M.
    Haematologica; 2003 Mar; 88(3):286-9. PubMed ID: 12651267
    [Abstract] [Full Text] [Related]

  • 24. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B.
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [Abstract] [Full Text] [Related]

  • 25. [Analysis of phenotype resistance to activated protein C (APC resistance)].
    Hudecek J, Ivanková J, Dobrotová M, Hybenová J, Pullmann R, Kubisz P.
    Vnitr Lek; 1999 Dec; 45(12):723-8. PubMed ID: 10951849
    [Abstract] [Full Text] [Related]

  • 26. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
    Delahousse B, Iochmann S, Pouplard C, Fimbel B, Charbonnier B, Gruel Y.
    Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
    [Abstract] [Full Text] [Related]

  • 27. Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients.
    Montes MA, Fox EA, Longtine JA, Dorfman DM.
    Arch Pathol Lab Med; 1998 Apr; 122(4):325-9. PubMed ID: 9648899
    [Abstract] [Full Text] [Related]

  • 28. A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V gene.
    Yamakage N, Ikejiri M, Okumura K, Takagi A, Murate T, Matushita T, Naoe T, Yamamoto K, Takamatsu J, Yamazaki T, Hamaguchi M, Kojima T.
    Haemophilia; 2006 Mar; 12(2):172-8. PubMed ID: 16476093
    [Abstract] [Full Text] [Related]

  • 29. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M, Stocker C, Bühler B, Conell B, Calatzis A.
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [Abstract] [Full Text] [Related]

  • 30. The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey.
    Gürgey A, Mesci L.
    Turk J Pediatr; 1997 Dec; 39(3):313-5. PubMed ID: 9339109
    [Abstract] [Full Text] [Related]

  • 31. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B.
    J Intern Med Suppl; 1997 Dec; 740():1-8. PubMed ID: 9350175
    [Abstract] [Full Text] [Related]

  • 32. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM, Simioni P, Bernardi F, Tormene D, Lunghi B, Tans G, Pagnan A, Rosing J, Castoldi E.
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [Abstract] [Full Text] [Related]

  • 33. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçiner A, Laleli YR, Gözükirmizi N.
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [Abstract] [Full Text] [Related]

  • 34. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 35. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP.
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [Abstract] [Full Text] [Related]

  • 36. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ, Benoni G, Fredin H, Björgell O, Nilsson P, Hedlund U, Nylander G, Bergqvist D, Dahlbäck B.
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [Abstract] [Full Text] [Related]

  • 39. [Gene analysis of five inherited factor V deficiency cases].
    Cao LJ, Wang ZY, Su YH, Yang HY, Zhao XJ, Zhang W, Yu ZQ, Bai X, Ruan CG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):145-8. PubMed ID: 18788609
    [Abstract] [Full Text] [Related]

  • 40. [Identification of two novel mutations of human blood coagulation factor V gene in a Chinese family with congenital factor V deficiency].
    Zheng WD, Liu YH, Liu HF, Chen ZH, Wang Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):515-8. PubMed ID: 17029198
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.